---
title: "What's Going On With Bristol Myers Squibb Stock Friday?"
description: "Bristol Myers Squibb & Co. ( NYSE:BMY ) on Friday agreed to acquire Orbital Therapeutics, a privately held biotechnology company focused on RNA medicines that reprogram the immune system in vivo. The "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/260665907.md"
published_at: "2025-10-10T15:36:58.000Z"
---

# What's Going On With Bristol Myers Squibb Stock Friday?

> Bristol Myers Squibb & Co. ( NYSE:BMY ) on Friday agreed to acquire Orbital Therapeutics, a privately held biotechnology company focused on RNA medicines that reprogram the immune system in vivo. The US drug giant agreed to pay $1.5 billion in cash.

Bristol Myers Squibb & Co. ( NYSE:BMY ) on Friday agreed to acquire Orbital Therapeutics, a privately held biotechnology company focused on RNA medicines that reprogram the immune system in vivo. The US drug giant agreed to pay $1.5 billion in cash.

### Related Stocks

- [BMY.US - Bristol Myers Squibb](https://longbridge.com/en/quote/BMY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Bristol Myers Squibb Releases Fourth Quarter and Full-Year 2025 Financial Results | Bristol-Myers Squibb Company has released its fourth quarter and full-year 2025 financial results. The earnings press re | [Link](https://longbridge.com/en/news/274966941.md) |
| How Is The Market Feeling About Bristol-Myers Squibb Co? | Bristol-Myers Squibb Co's short interest has increased by 3.45%, with 36.58 million shares sold short, representing 1.8% | [Link](https://longbridge.com/en/news/272839154.md) |
| Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture? | Bristol-Myers Squibb (NYSE:BMY) has seen significant bullish options activity, with 55% of investors leaning bullish. Th | [Link](https://longbridge.com/en/news/271354226.md) |
| Bristol Myers Squibb Company $BMY Shares Sold by Concurrent Investment Advisors LLC | Concurrent Investment Advisors LLC reduced its stake in Bristol Myers Squibb Company (NYSE:BMY) by 33.3% in Q3, owning 5 | [Link](https://longbridge.com/en/news/272811797.md) |
| KG&L Capital Management LLC Has $1.07 Million Stock Holdings in Bristol Myers Squibb Company $BMY | KG&L Capital Management LLC reduced its stake in Bristol Myers Squibb Company (NYSE:BMY) by 49.4% in Q3, holding 23,599  | [Link](https://longbridge.com/en/news/271643261.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.